publication venue for
- Persistent hematopoietic polyclonality after lentivirus-mediated gene therapy for Fabry disease. 28:262-271. 2023
- Production and purification of high-titer OrfV for preclinical studies in vaccinology and cancer therapy. 23:434-447. 2021
- Quantifying Antibody Responses Induced by Antigen-Agnostic Immunotherapies. 14:189-196. 2019
- Quantifying Antigen-Specific T Cell Responses When Using Antigen-Agnostic Immunotherapies. 13:154-166. 2019
- Production and Purification of High-Titer Newcastle Disease Virus for Use in Preclinical Mouse Models of Cancer. 9:181-191. 2018
- Lentivector Iterations and Pre-Clinical Scale-Up/Toxicity Testing: Targeting Mobilized CD34 + Cells for Correction of Fabry Disease. 5:241-258. 2017
- Methods and clinical development of adenovirus-vectored vaccines against mucosal pathogens. 3:16030-16030. 2016
- Type 1 interferon gene transfer enhances host defense against pulmonary Streptococcus pneumoniae infection via activating innate leukocytes. 1:5-5. 2014